Clinical trial
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
NCT02041091 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2014
- Completion date
- November 30, 2015
- Enrollment
- 226 (actual)
- Sites
- 44
Conditions
As the registry lists them; a condition with its own page is linked.